The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis

Alen Zabotti, Delia Goletti, Ennio Lubrano, Fabrizio Cantini

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences